Hepatitis C prevalence and risk factors in Georgia, 2015: setting a baseline for elimination

被引：44

作者：

Hagan, Liesl M. ^{[1
]}

Kasradze, Ana ^{[2
]}

Salyer, Stephanie J. ^{[3
]}

Gamkrelidze, Amiran ^{[2
]}

Alkhazashvili, Maia ^{[2
]}

Chanturia, Gvantsa ^{[2
]}

Chitadze, Nazibrola ^{[2
]}

Sukhiashvili, Roena ^{[2
]}

Shakhnazarova, Marina ^{[2
]}

Russell, Steven ^{[3
]}

Blanton, Curtis ^{[3
]}

Kuchukhidze, Giorgi ^{[2
]}

Baliashvili, Davit ^{[2
]}

Hariri, Susan ^{[1
]}

Ko, Stephen ^{[1
,4
]}

Imnadze, Paata ^{[2
]}

Drobeniuc, Jan ^{[1
]}

Morgan, Juliette ^{[3
,5
]}

Averhoff, Francisco ^{[1
]}

机构：

[1] Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA 30333 USA

[2] Natl Ctr Dis Control & Publ Hlth, Tbilisi, Georgia

[3] Ctr Dis Control & Prevent, Div Global Hlth Protect, Atlanta, GA USA

[4] Boston Univ, Sch Publ Hlth, Boston, MA USA

[5] Ctr Dis Control & Prevent, Global Dis Detect South Caucasus Reg Ctr, Tbilisi, Georgia

来源：

BMC PUBLIC HEALTH | 2019年 / 19卷 / Suppl 3期

关键词：

Hepatitis C virus; HCV; HCV elimination; Georgia; HCV prevention; Global health security; HOMELESS COMMUNITY; NATIONAL PROGRESS; B-VIRUS; INFECTIONS; HIV;

D O I：

10.1186/s12889-019-6784-3

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

BackgroundThe country of Georgia launched the world's first Hepatitis C Virus (HCV) Elimination Program in 2015 and set a 90% prevalence reduction goal for 2020. We conducted a nationally representative HCV seroprevalence survey to establish baseline prevalence to measure progress toward elimination over time.MethodsA cross-sectional seroprevalence survey was conducted in 2015 among adults aged 18years using a stratified, multi-stage cluster design (n=7000). Questionnaire variables included demographic, medical, and behavioral risk characteristics and HCV-related knowledge. Blood specimens were tested for antibodies to HCV (anti-HCV) and HCV RNA. Frequencies were computed for HCV prevalence, risk factors, and HCV-related knowledge. Associations between anti-HCV status and potential risk factors were calculated using logistic regression.ResultsNational anti-HCV seroprevalence in Georgia was 7.7% (95% confidence interval (CI)=6.7,8.9); HCV RNA prevalence was 5.4% (95% CI=4.6, 6.4). Testing anti-HCV+ was significantly associated with male sex, unemployment, urban residence, history of injection drug use (IDU), incarceration, blood transfusion, tattoos, frequent dental cleanings, medical injections, dialysis, and multiple lifetime sexual partners. History of IDU (adjusted odds ratio (AOR)=21.4, 95% CI=12.3, 37.4) and blood transfusion (AOR=4.5, 95% CI=2.8, 7.2) were independently, significantly associated with testing anti-HCV+ after controlling for sex, age, urban vs. rural residence, and history of incarceration. Among anti-HCV+ participants, 64.0% were unaware of their HCV status, and 46.7% did not report IDU or blood transfusion as a risk factor.ConclusionsGeorgia has a high HCV burden, and a majority of infected persons are unaware of their status. Ensuring a safe blood supply, implementing innovative screening strategies beyond a risk-based approach, and intensifying prevention efforts among persons who inject drugs are necessary steps to reach Georgia's HCV elimination goal.

引用

页数：12

共 24 条

[21] Prevalence of hepatitis C, HIV, and risk behaviors for blood-borne infections: A population-based survey of the adult population of T'bilisi, Republic of Georgia [J].

Stvilia, K ;

Tsertsvadze, T ;

Sharvadze, L ;

Aladashvili, M ;

Del Rio, C ;

Kuniholm, MH ;

Nelson, KE .

JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 2006, 83 (02) :289-298

[22] RETRACTED: A survey of hepatitis B and C prevalence amongst the homeless community of Prague (Retracted article. See vol 19, pg 443, 2009) [J].

Volf, Vladimir ;

Marx, David ;

Pliskova, Ludmila ;

Sumegh, Laszlo ;

Celko, Alexander .

EUROPEAN JOURNAL OF PUBLIC HEALTH, 2008, 18 (01) :44-47

[23]

WHO, 2016, Combating hepatitis B and C to reach elimination by 2030

[24]

World Health Organization, 2017, WHO Publishes List of Bacteria for Which New Antibiotics Are Urgently Needed

← 1 2 3 →